Nan F[au] - Search Results

Year	Number of Results
1993	1
1998	1
1999	1
2000	3
2001	2
2002	1
2003	4
2004	9
2005	7
2006	14
2007	9
2008	11
2009	14
2010	13
2011	9
2012	16
2013	16
2014	27
2015	25
2016	36
2017	21
2018	43
2019	41
2020	47
2021	52
2022	72
2023	19

1

Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity.

Liu CX, Li X, Nan F, Jiang S, Gao X, Guo SK, Xue W, Cui Y, Dong K, Ding H, Qu B, Zhou Z, Shen N, Yang L, Chen LL. Liu CX, et al. Among authors: nan f. Cell. 2019 May 2;177(4):865-880.e21. doi: 10.1016/j.cell.2019.03.046. Epub 2019 Apr 25. Cell. 2019. PMID: 31031002 Free article.

2

Excessive intake of sugar: An accomplice of inflammation.

Ma X, Nan F, Liang H, Shu P, Fan X, Song X, Hou Y, Zhang D. Ma X, et al. Among authors: nan f. Front Immunol. 2022 Aug 31;13:988481. doi: 10.3389/fimmu.2022.988481. eCollection 2022. Front Immunol. 2022. PMID: 36119103 Free PMC article. Review.

3

lncRNA SLERT controls phase separation of FC/DFCs to facilitate Pol I transcription.

Wu M, Xu G, Han C, Luan PF, Xing YH, Nan F, Yang LZ, Huang Y, Yang ZH, Shan L, Yang L, Liu J, Chen LL. Wu M, et al. Among authors: nan f. Science. 2021 Jul 30;373(6554):547-555. doi: 10.1126/science.abf6582. Science. 2021. PMID: 34326237

4

RNA circles with minimized immunogenicity as potent PKR inhibitors.

Liu CX, Guo SK, Nan F, Xu YF, Yang L, Chen LL. Liu CX, et al. Among authors: nan f. Mol Cell. 2022 Jan 20;82(2):420-434.e6. doi: 10.1016/j.molcel.2021.11.019. Epub 2021 Dec 23. Mol Cell. 2022. PMID: 34951963 Free article.

5

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma.

Zhang M, Chen D, Fu X, Meng H, Nan F, Sun Z, Yu H, Zhang L, Li L, Li X, Wang X, Wang M, You F, Li Z, Chang Y, Zhou Z, Yan J, Li J, Wu X, Wang Y, Wang Y, Xiang S, Chen Y, Pan G, Xu H, Zhang B, Yang L. Zhang M, et al. Among authors: nan f. Clin Cancer Res. 2022 Jul 1;28(13):2830-2843. doi: 10.1158/1078-0432.CCR-21-4097. Clin Cancer Res. 2022. PMID: 35435984 Clinical Trial.

6

Structural basis of GPBAR activation and bile acid recognition.

Yang F, Mao C, Guo L, Lin J, Ming Q, Xiao P, Wu X, Shen Q, Guo S, Shen DD, Lu R, Zhang L, Huang S, Ping Y, Zhang C, Ma C, Zhang K, Liang X, Shen Y, Nan F, Yi F, Luca VC, Zhou J, Jiang C, Sun JP, Xie X, Yu X, Zhang Y. Yang F, et al. Among authors: nan f. Nature. 2020 Nov;587(7834):499-504. doi: 10.1038/s41586-020-2569-1. Epub 2020 Jul 22. Nature. 2020. PMID: 32698187

7

GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages.

Zhang Q, Chen LH, Yang H, Fang YC, Wang SW, Wang M, Yuan QT, Wu W, Zhang YM, Liu ZJ, Nan FJ, Xie X. Zhang Q, et al. Among authors: nan fj. Acta Pharmacol Sin. 2022 Aug;43(8):2042-2054. doi: 10.1038/s41401-021-00825-y. Epub 2021 Dec 15. Acta Pharmacol Sin. 2022. PMID: 34912006 Free PMC article.

8

The metabolic ER stress sensor IRE1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity.

Shan B, Wang X, Wu Y, Xu C, Xia Z, Dai J, Shao M, Zhao F, He S, Yang L, Zhang M, Nan F, Li J, Liu J, Liu J, Jia W, Qiu Y, Song B, Han JJ, Rui L, Duan SZ, Liu Y. Shan B, et al. Among authors: nan f. Nat Immunol. 2017 May;18(5):519-529. doi: 10.1038/ni.3709. Epub 2017 Mar 27. Nat Immunol. 2017. PMID: 28346409

9

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.

Wang X, Zhang L, Liu X, Li X, Li L, Fu X, Sun Z, Wu J, Zhang X, Yan J, Chang Y, Nan F, Zhou Z, Wu X, Tian L, Ma M, Li Z, Yu H, Zhu L, Wang Y, Shi C, Feng X, Li J, Ding M, Zhang J, Dong M, Xue H, Wang J, Zou L, Su L, Wu J, Liu L, Bao H, Zhang L, Guo Y, Guo S, Lu Y, Young KH, Li W, Zhang M. Wang X, et al. Among authors: nan f. JAMA Oncol. 2022 Jul 1;8(7):1035-1041. doi: 10.1001/jamaoncol.2022.1968. JAMA Oncol. 2022. PMID: 35708709 Clinical Trial.

10

mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice.

Zhuang X, Qi Y, Wang M, Yu N, Nan F, Zhang H, Tian M, Li C, Lu H, Jin N. Zhuang X, et al. Among authors: nan f. Vaccines (Basel). 2020 Mar 10;8(1):123. doi: 10.3390/vaccines8010123. Vaccines (Basel). 2020. PMID: 32164372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results